Stocktoria
Nkarta, Inc. NKTX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-07-10
Nkarta, Inc. statistics & valuation
Market cap$202.5M
P / B0.6×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -25.8% | -21.7% | -31.0% | -24.1% | -31.4% |
| Return on equity | -33.3% | -26.7% | -43.0% | -30.6% | -34.3% |
| Current ratio | 12.69 | 14.45 | 10.85 | 16.36 | 18.99 |
Source: SEC EDGAR filings · CIK 0001787400 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.